Veralipride
Title: Veralipride
CAS Registry Number: 66644-81-3
CAS Name: 5-(Aminosulfonyl)-2,3-dimethoxy-N-[[1-(2-propenyl)-2-pyrrolidinyl]methyl]benzamide
Additional Names: N-[(1-allyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-veratramide
Manufacturers' Codes: LIR-1660
Trademarks: Agréal (Delagrange); Agradil (Synthelabo); Veralipril (Midy)
Molecular Formula: C17H25N3O5S
Molecular Weight: 383.46
Percent Composition: C 53.25%, H 6.57%, N 10.96%, O 20.86%, S 8.36%
Literature References: Prepn: NL 7707982 (1978 to Soc. d'Etudes Sci. Ind. de l'Ile-de-France), C.A. 89, 30768 (1978). Pharmacological studies: P. Bouyard et al., Sem. Hop. 56, 1475 (1980); J. C. Czyba, ibid. 1483. Clinical studies: R. Renaud, J. Macler, ibid. 57, 353 (1981); S. Angeli, P. Fougère, ibid. 58, 111 (1982).
Therap-Cat: Treatment of menopausal disorders.

Others monographs:
QuinoneSilicic Acid1-PentolCrilanomer
RociverineDesfluraneSemduramicinChlorcyclizine
Potassium Hexacyanocobaltate(III)DyphyllineVeratric Acid2-Mercaptoethanol
Strontium SelenateZimeldine2,4-DifluoroanilineArecaidine
©2016 DrugLead US FDA&EMEA